Gliclazid Spirig HC Retard 60 mg, Tabletten mit veränderter Wirkstofffreisetzung
7680654410047
CH-65441
Tabletten mit veränderter Wirkstofffreisetzung
Associated product:
GLICLAZIDE Spirig HC Retard cpr ret 60 mg 120 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 120
- Selling units
- 120
- Measure
- Tablette(n)
- Galenic form
- Tabletten mit veränderter Wirkstofffreisetzung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
gliclazidum
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
163.8 MG | Substance | HBESI |
|
hypromellosum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 43.35
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2015
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 65441
- Drug name
- Gliclazid Spirig HC Retard, Tabletten mit veränderter Wirkstofffreisetzung
- Galenic form
- RETT
- ATC Code
- A10BB09
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 09/06/2015
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.06.2.
- Domain
- Human medicine
Package details
- Description (FR)
- GLICLAZIDE Spirig HC Retard cpr ret 60 mg 120 pce
- Description (DE)
- GLICLAZID Spirig HC Retard Ret Tabl 60 mg 120 Stk
- Market launch
- 09/06/2015
- Narcotic (BTM)
- No
Original drug
Diamicron MR, comprimés à libération modifiée
GTIN: 7680552340064
CHF 18.20